Clinical Study of Genakumab for Injection in Patients With Acute Gout
Clinical trial NCT05328531 · COMPLETED
Trial details
- NCT number
- NCT05328531
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-22
- Primary completion
- 2022-06-09
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.